Creative Biolabs-Immuno-oncology

Anti-CD79B (clone HuMA7J9Qbv2E8P) SynExpress C-Cy3-I10-E Modified CD8+ T cells (CAT#: ITS-1224-CR1846)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD79B (clone HuMA7J9Qbv2E8P). We employs the Retrovirus (CMV-Cy3-IL-10-EcoRI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
CD79B
Clone
HuMA7J9Qbv2E8P
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
CMV
Effector Gene
IL-10
Insertion Sites
EcoRI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
Retrovirus
Transformation Accuracy
0.86
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving